Prognostic significance of phosphorylated signal transducer and activator of transcription 3 and suppressor of cytokine signaling 3 expression in hepatocellular carcinoma

  • Authors:
    • Wen-Yong Wu
    • Jun Li
    • Zheng-Sheng Wu
    • Chang-Le Zhang
    • Xiang-Ling Meng
    • Peter E. Lobie
  • View Affiliations

  • Published online on: April 11, 2011     https://doi.org/10.3892/etm.2011.254
  • Pages: 647-653
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Altered expression of phosphorylated signal transducer and activator of transcription 3 (pSTAT3) and suppressor of cytokine signaling 3 (SOCS3) has been implicated in various types of human cancers. However, the clinical role of pSTAT3 and SOCS3 in hepatocellular carcinoma (HCC) is not well established. Immunohistochemical analysis of pSTAT3, SOCS3, Ki67 and VEGF expression was performed on tissue microarrays from 138 HCC patients. The expression of STAT3 mRNA was further detected by in situ hybridization. The association of pSTAT3 and SOCS3 expression with clinicopathological factors and patient survival was analyzed. Altered expression of pSTAT3 and SOCS3 was observed in HCC specimens, compared to adjacent non-tumor tissue. Increased expression of pSTAT3 was correlated with large tumor size, higher clinical stage, Ki67 and VEGF expression, as well as poor patient survival. Decreased expression of SOCS3 was correlated with the expression of Ki67, VEGF and pSTAT3, and poor patient survival. Moreover, the expression of pSTAT3 was conversely correlated with SOCS3 expression in HCC. Our results indicate that deregulated expression of pSTAT3 and SOCS3 may play roles in the development and progression of HCC. PSTAT3 and SOCS3 should be further evaluated as potential novel biomarkers for HCC prognosis.
View Figures
View References

Related Articles

Journal Cover

July-August 2011
Volume 2 Issue 4

Print ISSN: 1792-0981
Online ISSN:1792-1015

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Wu W, Li J, Wu Z, Zhang C, Meng X and Lobie PE: Prognostic significance of phosphorylated signal transducer and activator of transcription 3 and suppressor of cytokine signaling 3 expression in hepatocellular carcinoma. Exp Ther Med 2: 647-653, 2011.
APA
Wu, W., Li, J., Wu, Z., Zhang, C., Meng, X., & Lobie, P.E. (2011). Prognostic significance of phosphorylated signal transducer and activator of transcription 3 and suppressor of cytokine signaling 3 expression in hepatocellular carcinoma. Experimental and Therapeutic Medicine, 2, 647-653. https://doi.org/10.3892/etm.2011.254
MLA
Wu, W., Li, J., Wu, Z., Zhang, C., Meng, X., Lobie, P. E."Prognostic significance of phosphorylated signal transducer and activator of transcription 3 and suppressor of cytokine signaling 3 expression in hepatocellular carcinoma". Experimental and Therapeutic Medicine 2.4 (2011): 647-653.
Chicago
Wu, W., Li, J., Wu, Z., Zhang, C., Meng, X., Lobie, P. E."Prognostic significance of phosphorylated signal transducer and activator of transcription 3 and suppressor of cytokine signaling 3 expression in hepatocellular carcinoma". Experimental and Therapeutic Medicine 2, no. 4 (2011): 647-653. https://doi.org/10.3892/etm.2011.254